Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. R. Wijsman

Publicaties

"AI tumor delineation for all breathing phases in early-stage NSCLC"

Association between dose to cardiac structures and overall survival: A multivariable analysis in a large, multi-institutional database of stage III NSCLC patients with external validation

Impact of Heart and Lung Dosimetry on RV Function in Lung and Oesophageal Cancer Patients

Patient selection for proton therapy in lung cancer: Nationwide external validation and model update of a prognostic model for 2-year mortality including mean heart dose

Predicted Outcome Benefits of Static and Dynamic Proton Arc Therapy Compared to Intensity-Modulated Proton Therapy for Non-Small Cell Lung Cancer

Recovery of quality of life in 574 patients with inoperable lung cancer undergoing (chemo)radiotherapy

Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy

A planning study of proton therapy dose escalation for non-small cell lung cancer

Baseline Blood CD8+ T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer

Cardiac effects after lung and oesophageal cancer radiotherapy